Conference Proceedings
PROGRESS - perindopril protection against recurrent stroke study: Status in July 1996
J Chalmers, S MacMahon, MG Bousser, J Cutler, G Donnan, L Hansson, S Harrap, L Lisheng, G Mancia, J Menard, T Omae, J Reid, A Rodgers, C Warlow, A Culpan, R Currie, S Flett, B Neal, A Milne, S Davis Show all
Journal of Hypertension Supplement | LIPPINCOTT WILLIAMS & WILKINS | Published : 1996
Abstract
Objectives. The primary objective of PROGRESS is to determine reliably the efficacy of lowering blood pressure for the prevention of stroke in patients with a history of cerebrovascular disease. Design. PROGRESS is a randomized, double-blind, placebo-controlled trial investigating the effects on the incidence of stroke and other major cardiovascular events and dementia of treatment with the angiotensin-converting enzyme inhibitor perindopril, alone or in combination with the diuretic indapamide. Methods. The study population comprises 6000 normotensive or hypertensive patients with a history of stroke or transient ischaemic attack within the previous 5 years. The study is being conducted in ..
View full abstract